The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis

Atherosclerosis

Volumn 184, Issue 2, 2006, Pages 342-347

  Aristoteli, Lina Panayiota ^a   Møller, Holger Jon ^b   Bailey, Brian ^d   Moestrup, Søren Kragh ^c   Kritharides, Leonard ^a,d,e  

^a HEART RESEARCH INSTITUTE   (Australia)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Atherosclerosis; Biomarker; Cardiovascular; CD163; Macrophage

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CALCIUM ANTAGONIST; CD163 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODYNAMICS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, CELL SURFACE; RECEPTORS, SCAVENGER; SEVERITY OF ILLNESS INDEX;

EID: 30044433255     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.05.004     Document Type: Article

References (34)

1. G.J. Blake, and P.M. Ridker Novel clinical markers of vascular wall inflammation Circ Res 89 2001 763 771
2. R. Russell Mechanisms of disease: atherosclerosis - an inflammatory disease N Engl J Med 340 1999 115 126
3. M. Kristiansen, J.H. Graversen, and C. Jacobsen Identification of the haemoglobin scavenger receptor Nature 409 2001 198 201
4. P. Högger, J. Dreier, A. Droste, F. Buck, and C. Sorg Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163) J Immunol 161 1998 1883 1890
5. T.H. Sulahian, P. Högger, and A.E. Wahner Human monocytes express CD163, which is upregulated by IL-10 and identical to p155 Cytokine 12 2000 1312 1321
6. M. Ritter, C. Buechler, and T. Langmann The scavenger receptor CD163: regulation promoter structure and genomic organization Pathobiology 67 1999 257 261
7. D.J. Schaer, F.S. Boretti, G. Schoedon, and A. Schaffner Induction of the CD163-dependent haemoglobin uptake by macrophages as a novel anti-inflammatory action of glucocorticoids Br J Haematol 119 2002 239 243
8. T.H. Sulahian, P.A. Pioli, K. Wardwell, and P.M. Guyre Cross-linking of FcgR triggers shedding of the hemoglobin-haptoglobin scavenger receptor CD163 J Leukoc Biol 76 2004 271 277
9. C. Buechler, M. Ritter, and E. Orsó Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli J Leukoc Biol 67 2000 97 103
10. H.J. Møller, N.A. Peterslund, J.H. Graversen, and S.K. Moestrup Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma Blood 99 2002 378 380
11. N. Matsushita, M. Kashiwagi, and R. Wait Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3 Clin Exp Immunol 130 2002 156 161
12. A. Droste, C. Sorg, and P. Högger Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family Biochem Biophys Res Comm 256 1999 110 113
13. K.A. Hintz, A.J. Rassias, and K. Wardwell Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163 J Leukoc Biol 72 2002 711 717
14. W. Frings, J. Dreier, and C. Sorg Only the soluble form of the scavenger receptor CD163 acts inhibitory on phorbol ester-activated T-lymphocytes, whereas membrane-bound protein has no effect FEBS Lett 526 2002 93 96
15. P. Högger, and C. Sorg Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation Biochem Biophys Res Comm 288 2001 841 843
16. J.E. Fonseca, J.C.W. Edwards, S. Blades, and N.J. Goulding Macrophage subpopulations in rheumatoid synovium - reduced CD163 expression in CD4+ T lymphocyte-rich microenvironments Arth Rheum 46 2002 1210 1216
17. H.J. Møller, M. de Fost, H. Aerts, C. Hollak, and S.K. Moestrup Plasma level of the macrophage-derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease Eur J Haematol 72 2004 135 139
18. D.J. Schaer, B. Schleiffenbaum, and E.B. Bächli Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage specific marker in the reactive hemophagocytic syndrome Eur J Haematol 74 1 2005 6 10
19. R.B. Walter, E.B. Bächli, D.J. Schaer, R. Rüegg, and G. Schoedon Expression of the hemoglobin scavenger receptor (CD163/HbSR) as immunophenotypic marker of monocytic lineage in acute myeloid leukemia Blood 101 2003 3755 3756
20. B.H. Davis, and P.V. Zarev Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels Cytometry 63B 2005 16 22
21. N.R. Ratcliffe, S.M. Kennedy, and P.M. Morganelli Immunocytochemical detection of Fcg receptors in human atherosclerotic lesions Immunol Lett 77 2001 169 174
22. N.C.A.S. Study A multicenter comparison of the effects of randomized medical and surgical treatment of mildly symptomatic patients with coronary artery disease, and a registry of consecutive patients undergoing coronary angiography Circulation 63 1981 1 81
23. G. Gensini Coronary Arteriography 1975 Futura Publishing Co Mount Kisco, New York
24. H.J. Møller, K. Hald, and S.K. Moestrup Characterisation of an enzyme-linked immunosorbent assay for soluble CD163 Scand J Clin Lab Invest 62 2002 293 300
25. H.J. Møller, H. Aerts, and H. Grønbæk Soluble CD163: a marker molecule for monocyte/macrophage activity in disease Scand J Clin Lab Invest 62 2002 29 34
26. A.P. Levy Genetics of diabetic cardiovascular disease: identification of a major susceptibility gene Acta Diabetol 40 2003 S330 S333
27. R. Asleh, S. Marsh, and M. Shilkrut Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease Circ Res 92 2003 1193 1200
28. E. Moura, M.A. Noordemeer, N. Verhoeven, A.F.M. Verheul, and J.J.M. Marx Iron release from human monocytes after erythrophagocytosis in vitro: an investigation in normal subjects and hereditary hemochromocytosis patients Blood 92 1998 2511 2519
29. X.M. Yuan, W. Li, A.G. Olsson, and U.T. Brunk Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis Atherosclerosis 124 1996 61 73
30. W. Diederich, E. Orsó, W. Drobnik, and G. Schmitz Apolipoprotein AI and HDL3 inhibit spreading of primary human monocytes through a mechanism that involves cholesterol depletion and regulation of CDC42 Atherosclerosis 159 2001 313 324
31. L. Lind Circulating markers of inflammation and atherosclerosis Atherosclerosis 169 2003 203 214
32. R. Arroyo-Espliguero, P. Avanzas, and J. Cosin-Sales C-reactive protein elevation and disease activity in patients with coronary artery disease Eur Heart J 25 2004 401 408
33. J. Danesh, J.G. Wheeler, and G.M. Hirschfield C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N Engl J Med 350 2004 1387 1397
34. H. Taniguchi, Y. Momiyama, and R. Ohmori Associations of plasma C-reactive protein levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease Atherosclerosis 178 2005 173 177